The government introduced a draft law to the parliament with amendments to the Civil Code that would allow producing of medicines without the consent of the patent holder.
The document was prepared by the Federal Antimonopoly Service (FAS) as part of the implementation of the National Competition Development Plan for 2018–2020.
After the adoption of the law, if necessary, related to ensuring defense and security, including protecting the life and health of citizens, the government will be able to decide on the use of an invention, utility model or industrial design without the consent of the patent holder.
The rightsholder will be notified of this and receive proportionate compensation. The methodology for determining the amount of compensation and the procedure for its payment will also be determined by the government.
It is planned that this will provide an opportunity to quickly supply for the absence or shortage in the country of foreign patented medicines and medical devices.
As stated by the FAS, in recent years there have been cases when foreign large corporations refused to supply vital medicines to Russia.